Peach Property Group Valuation
Is PEANZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of PEANZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PEANZ (CHF8.5) is trading above our estimate of fair value (CHF3.89)
Significantly Below Fair Value: PEANZ is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PEANZ?
Other financial metrics that can be useful for relative valuation.
| What is PEANZ's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | €203.47m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 13x |
| Enterprise Value/EBITDA | 31.6x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PEANZ's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.1x | ||
WINK M Winkworth | 2.6x | 7.4% | UK£26.6m |
FPO First Property Group | 2x | n/a | UK£15.5m |
FOXT Foxtons Group | 1.2x | 5.5% | UK£193.0m |
PSDL Phoenix Spree Deutschland | 6.6x | -11.5% | UK£152.9m |
PEANZ Peach Property Group | 1.6x | 8.2% | CHF 193.2m |
Price-To-Sales vs Peers: PEANZ is good value based on its Price-To-Sales Ratio (1.6x) compared to the peer average (3.2x).
Price to Earnings Ratio vs Industry
How does PEANZ's PE Ratio compare vs other companies in the GB Real Estate Industry?
Price-To-Sales vs Industry: PEANZ is good value based on its Price-To-Sales Ratio (1.6x) compared to the UK Real Estate industry average (4.1x).
Price to Sales Ratio vs Fair Ratio
What is PEANZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 1.6x |
| Fair PS Ratio | 3.5x |
Price-To-Sales vs Fair Ratio: PEANZ is good value based on its Price-To-Sales Ratio (1.6x) compared to the estimated Fair Price-To-Sales Ratio (3.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | CHF 8.50 | CHF 13.10 +54.1% | 49.0% | CHF 25.00 | CHF 5.50 | n/a | 5 |
| Sep ’25 | CHF 7.17 | CHF 13.10 +82.7% | 49.0% | CHF 25.00 | CHF 5.50 | n/a | 5 |
| Aug ’25 | CHF 7.30 | CHF 15.00 +105.5% | 34.5% | CHF 25.00 | CHF 11.00 | n/a | 5 |
| Jul ’25 | CHF 7.20 | CHF 15.00 +108.3% | 34.5% | CHF 25.00 | CHF 11.00 | n/a | 5 |
| Jun ’25 | CHF 8.64 | CHF 16.67 +92.9% | 36.1% | CHF 25.00 | CHF 11.00 | n/a | 6 |
| May ’25 | CHF 9.61 | CHF 16.67 +73.4% | 36.1% | CHF 25.00 | CHF 11.00 | n/a | 6 |
| Apr ’25 | CHF 11.64 | CHF 16.50 +41.8% | 37.3% | CHF 25.00 | CHF 11.00 | n/a | 6 |
| Mar ’25 | CHF 8.08 | CHF 19.53 +141.7% | 45.1% | CHF 32.20 | CHF 10.00 | n/a | 6 |
| Feb ’25 | CHF 10.20 | CHF 23.70 +132.4% | 40.8% | CHF 36.00 | CHF 10.00 | n/a | 6 |
| Jan ’25 | CHF 11.40 | CHF 24.20 +112.3% | 37.2% | CHF 36.00 | CHF 12.00 | n/a | 6 |
| Dec ’24 | CHF 11.10 | CHF 24.20 +118.0% | 37.2% | CHF 36.00 | CHF 12.00 | n/a | 6 |
| Nov ’24 | CHF 11.50 | CHF 24.20 +110.4% | 37.2% | CHF 36.00 | CHF 12.00 | n/a | 6 |
| Oct ’24 | CHF 13.10 | CHF 24.20 +84.7% | 37.2% | CHF 36.00 | CHF 12.00 | n/a | 6 |
| Sep ’24 | CHF 13.36 | CHF 25.25 +89.0% | 40.3% | CHF 38.50 | CHF 12.00 | CHF 7.17 | 6 |
| Aug ’24 | CHF 11.64 | CHF 30.30 +160.3% | 29.8% | CHF 38.50 | CHF 14.00 | CHF 7.30 | 5 |
| Jul ’24 | CHF 13.30 | CHF 30.30 +127.8% | 29.8% | CHF 38.50 | CHF 14.00 | CHF 7.20 | 5 |
| Jun ’24 | CHF 12.34 | CHF 30.30 +145.5% | 29.8% | CHF 38.50 | CHF 14.00 | CHF 8.64 | 5 |
| May ’24 | CHF 13.96 | CHF 30.30 +117.0% | 29.8% | CHF 38.50 | CHF 14.00 | CHF 9.61 | 5 |
| Apr ’24 | CHF 12.24 | CHF 29.67 +142.4% | 38.2% | CHF 47.00 | CHF 14.00 | CHF 11.64 | 6 |
| Mar ’24 | CHF 17.20 | CHF 39.27 +128.3% | 42.8% | CHF 70.00 | CHF 18.00 | CHF 8.08 | 7 |
| Feb ’24 | CHF 20.20 | CHF 43.06 +113.2% | 46.8% | CHF 70.40 | CHF 18.00 | CHF 10.20 | 7 |
| Jan ’24 | CHF 16.60 | CHF 44.63 +168.8% | 47.0% | CHF 70.40 | CHF 18.00 | CHF 11.40 | 7 |
| Dec ’23 | CHF 19.32 | CHF 61.30 +217.3% | 22.0% | CHF 74.80 | CHF 33.00 | CHF 11.10 | 6 |
| Nov ’23 | CHF 21.75 | CHF 61.30 +181.8% | 22.0% | CHF 74.80 | CHF 33.00 | CHF 11.50 | 6 |
| Oct ’23 | CHF 22.65 | CHF 61.30 +170.6% | 22.0% | CHF 74.80 | CHF 33.00 | CHF 13.10 | 6 |
| Sep ’23 | CHF 29.65 | CHF 64.63 +118.0% | 18.0% | CHF 74.80 | CHF 40.00 | CHF 13.36 | 6 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.